Table 3.

Symptoms of the “Flammer Syndrome” recorded in “Metastatic breast cancer patients” versus “Breast cancer-free individuals” groups of comparison

The table summarises the results demonstrated in Fig. 2; the following system is employed: “+” means higher prevalence of the corresponding symptom (above the lowest average of the groups of comparison); “−“ means lower prevalence of the corresponding symptom (lowest average and below it); “++“ means values sufficiently over the highest average. All 15 symptoms demonstrate increased prevalence in BC total versus BC-free. The level of significance is noted: p values below 0.05 are considered statistically significant and marked in red colour (symptoms 1, 2, 5, 7, 8, 9, 11). Thirteen symptoms united within the green-marked cluster demonstrate the prevalence ultimately increased in BC total as well as BC subgroups. Although the prevalence of symptoms 13 and 15 (yellow-marked cluster) is slightly increased in “BC total” compared to “BC-free,” it varies in BC subgroups demonstrating a particularly strong plurality amongst the patients with the metastatic BC investigated in the current study